sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> immunomodulators market

report

Immunomodulators Market, by Products (Immunosuppressant (Antibodies, Antimetabolites, Calcineurin Inhibitors, Glucocorticoids, Others), Immunostimulants (Antibodies, Vaccines, Others)), Applications (Respiratory, Oncology, HIV, Others) - Global Revenue, Trends, Growth, Share, Size, and Forecast to 2022

HC262 February 2017 100+ FREE 10% CUSTOMIZATION

An immunomodulator is any substance that helps to regulate the immune system. This regulation is a normalization process so that an immunomodulator contributes to optimizing immune response. The global immunomodulators market is expected to grow at a healthy Compound Annual Growth Rate (CAGR) during the forecast period. The growing incidences of various diseases and the advancing technologies are anticipated to play a crucial role in the rapid growth of this market by 2022.

This market research report on the immunomodulators market is focused on describing the growth trend and revenue opportunities for this industry on the global scale. The report carefully analyzes the global market by segmenting it based on the products, applications, and the major geographic regions. The report also tracks all the activities by the key market players, which include innovative business strategies, product launches, mergers & acquisitions, and the technological advancements.

OBJECTIVES & SCOPE OF THE REPORT

  • To forecast the market size, in terms of the market size and revenue for all its segments with respect the major geographic regions including North America, Europe, Asia-Pacific, and Rest of the World (Latin America, and Middle East & Africa)
  • To define the high-growth segments of the market and offer in-depth analysis of the competitive landscape in the market for various key players
  • To comprehensively analyze the strategic developments such as mergers & acquisition, new product launches, business expansions, and the new business agreements in this market

KEY PREMIUM INDUSTRY INSIGHTS

  • An increasing acceptance of early immunomodulator therapy for the treatment of Crohn's disease is expected to drive the immunomodulators market growth during the study period.
  • Furthermore, increasing prevalence of multiple sclerosis is projected to fuel the demand for the immunomodulators during the forecast period.
  • Also, the increasing incidences of rheumatoid arthritis are anticipated to boost the demand for the immunomodulator.
  • However, stringent U.S. FDA norms may hinder the growth of the immunomodulator market.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s immunomodulators market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the immunomodulators market by the following segments:

  • Immunomodulators Market, by Products
    • Immunosuppressant
      • Antibodies
      • Antimetabolites
      • Calcineurin Inhibitors
      • Glucocorticoids
      • Others
    • Immunostimulants
      • Antibodies
      • Vaccines
      • Others
  • Immunomodulators Market, by Applications
    • Respiratory
    • Oncology
    • HIV
    • Others

KEY MARKET PLAYERS

Key players in the immunomodulators market include:

  • F. Hoffmann-La Roche Ltd
  • Amgen Inc
  • Abbot
  • Novartis AG
  • Johnson & Johnson
  • Merck
  • Biogen Idec
  • Eli Lilly and Company
  • Bristol Myers Squibb Company

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Product Roadmap
  5. IMMUNOMODULATORS MARKET, BY PRODUCTS
    1. Segment Share
    2. Products
      1. Immunosuppressant
        1. Antibodies
        2. Antimetabolites
        3. Calcineurin Inhibitors
        4. Glucocorticoids
        5. Others
      2. Immunostimulants
        1. Antibodies
        2. Vaccines
        3. Others
  6. IMMUNOMODULATORS MARKET, BY APPLICATIONS
    1. Segment Share
    2. Applications
      1. Respiratory
      2. Oncology
      3. HIV
      4. Others
  7. IMMUNOMODULATORS MARKET, BY GEOGRAPHY
    1. North America
      1. By Country
        1. U.S.
        2. Rest of North America
      2. By Products
      3. By Applications
    2. Europe
      1. By Country
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Products
      3. By Applications
    3. Asia-Pacific
      1. By Country
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Products
      3. By Applications
    4. Rest of the World
      1. By Country
        1. Latin America
        2. Middle East & Africa
      2. By Products
      3. By Applications
  8. COMPETITIVE LANDSCAPE
    1. Market Share Analysis, 2015 (%)
    2. Key Innovators
  9. KEY MARKET PLAYERS
    1. F. Hoffmann-La Roche Ltd
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. Amgen Inc
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Abbot
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. Novartis AG
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Johnson & Johnson
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Merck
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Biogen Idec
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Eli Lilly and Company
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. Bristol Myers Squibb Company
      1. Overview
      2. Key Strategies
      3. Recent Developments
  10. SCALAR 360 DEGREE MARKET PERSPECTIVE
  11. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us